-
Review key studies and data relevant to the care of patients with bladder, prostate, and kidney cancers presented at the 2018 Genitourinary Cancers Symposium.
-
In this on-demand Webcast of a CCO symposium at ASCO GU 2018, Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD; Emmanuel S. Antonarakis, MBBCh, and Heather H. Cheng, MD, PhD, review and discuss the latest data on DNA repair defects, genetic testing, and the use of PARP inhibitors in men with prostate cancer.
-
In this expert analysis, John M. Burke, MD, and Christopher R. Flowers, MD, review and provide their perspective on key lymphomas and CLL studies presented at the Hematology 2017 annual meeting.
-
Expert faculty from the 2017-2018 CCO Local Live meeting series, “Expert Strategies to Optimize the Treatment of Patients With Squamous NSCLC,” answer frequently asked questions about treating squamous NSCLC, including considerations for newly diagnosed disease in special populations, choice of second-line immunotherapy, and management of immune-related adverse events.
-
Download this simple resource providing an overall summary of advanced NSCLC care including an up-to-date treatment algorithm, toxicity management, and a listing of key enrolling clinical trials.
|
Latest Content
-
| Edward B. Garon MD, MS - 4/16/2018 |
|
How will the new dosing schedule for nivolumab in NSCLC affect our current practice? Here are my thoughts.
-
Use this Interactive Decision Support Tool to get treatment recommendations from David R. Gandara, MD; Melissa L. Johnson, MD; Suresh S. Ramalingam, MD; Heather Wakelee, MD; and H. Jack West, MD, for your patients with advanced NSCLC.
Date Posted: 3/13/2018
-
Review key studies and data relevant to the care of patients with bladder, prostate, and kidney cancers presented at the 2018 Genitourinary Cancers Symposium.
Date Posted: 3/8/2018
-
In this case-based activity, gain evidence-based insights from international experts on therapeutic strategies for progressive metastatic colorectal cancer, from optimal sequencing of targeted agents to effective management of treatment-emergent adverse events.
Faculty: Khalid Alsaleh MD, FRCPC, Svetlana I. Kutukova MD, PhD, Suayib Yalcin MD
Released: 3/8/2018
-
In this on-demand Webcast of a CCO symposium at ASCO GU 2018, Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD; Emmanuel S. Antonarakis, MBBCh, and Heather H. Cheng, MD, PhD, review and discuss the latest data on DNA repair defects, genetic testing, and the use of PARP inhibitors in men with prostate cancer.
Faculty: Johann Sebastian de Bono MB, ChB, FRCP, MSc, PhD, Emmanuel S. Antonarakis MBBCh, Heather H. Cheng MD, PhD
Released: 3/6/2018
-
Download these slides from a live symposium on the assessment and management of adverse events associated with immune checkpoint therapy in the care of patients with stage III NSCLC.
Date Posted: 3/5/2018
-
Download these slides from a live symposium with expert insight on the optimal incorporation of immune checkpoint therapy into the care of patients with stage III NSCLC.
Date Posted: 3/5/2018
-
In this CE-certified downloadable slideset with slidenotes from the live meeting series, Maura Abbott, PhD, AOCNP, CPNP, reviews key data and nursing considerations for patients with NSCLC receiving immune checkpoint inhibitors, including case-based management of immune-related adverse events.
Faculty: Maura Abbott PhD, AOCNP, CPNP, Beth Eaby-Sandy MSN, CRNP, OCN
Released: 3/1/2018
-
In this expert analysis, John M. Burke, MD, and Christopher R. Flowers, MD, review and provide their perspective on key lymphomas and CLL studies presented at the Hematology 2017 annual meeting.
Faculty: John M. Burke MD, Christopher R. Flowers MD
Released: 2/27/2018
-
In this downloadable slideset, Bradley A. McGregor, MD, discusses the optimal treatment approaches and management options for patients with advanced RCC from an international perspective.
Date Posted: 2/27/2018
|
|
|